PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
Go back to PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀| (NASDAQ: PYPD) | Delayed: 5.45 +0.28 (5.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.17 | 52 Week High | $ | |||
| Open | $5.19 | 52 Week Low | $ | |||
| Day High | $5.46 | P/E | N/A | |||
| Day Low | $5.19 | EPS | $ | |||
| Volume | 127,009 | |||||
